United States Biotechnology & Medical Research

Iovance Biotherapeutics Inc (IOVA)

Track

Track

Iovance Biotherapeutics Inc. experienced recent insider activity during May and June 2025. Executives, including the Chief Commercial Officer, Chief Regulatory Officer, and Interim CEO, executed multiple share purchases. These acquisitions represent the most significant trading events, as no transactions occurred within the last three months.
Ticker: IOVA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Iovance Biotherapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.3
Kirby Daniel Gordon Chief Commercial Officer Officer
Transaction date
Purchase
Price
152.58
Quantity 65,854 +42.9%
Value US$4,230,550
3.1
Puri Raj K. Chief Regulatory Officer Officer
Transaction date
Purchase
Price
250.11
Quantity 66,236 +1.3%
Value US$3,411,752
4.0
Vogt Frederick G Interim CEO & General Counsel Executive Director
Transaction date
Purchase
Price
10.63
Quantity 15,007 +26.4%
Value US$4,039,378
3.3
Maynard Ryan D Non-Executive Director
Transaction date
Sale
Price
10.06
Quantity 50,000 -87.0%
Value US$503,000
3.3
Maynard Ryan D Director Non-Executive Director
Transaction date
Proposed sale
Price
10.06
Quantity 50,000
Value US$503,104
3.8
MCPEAK MERRILL A Non-Executive Director
Transaction date
Purchase
Price
9.15
Quantity 250,000 +356.4%
Value US$2,287,500
2.9
Rothbaum Wayne P. Non-Executive Director
Transaction date
Purchase
Price
9.15
Quantity 5,000,000 +21.7%
Value US$45,750,000
2.2
Dukes Iain D. Non-Executive Director
Transaction date
Purchase
Price
9.15
Quantity 32,000 +145.5%
Value US$292,800
3.8
MCPEAK MERRILL A Non-Executive Director
Transaction date
Purchase
Price
5.56
Quantity 10,000 +4.2%
Value US$55,600
2.9
Rothbaum Wayne P. Non-Executive Director
Transaction date
Purchase
Price
5.30
Quantity 5,000,000 +27.7%
Value US$26,500,000
3.8
MCPEAK MERRILL A Non-Executive Director
Transaction date
Purchase
Price
6.15
Quantity 10,000 +16.6%
Value US$61,500
2.9
Rothbaum Wayne P. Non-Executive Director
Transaction date
Purchase
Price
6.50
Quantity 10,000,000 +124.0%
Value US$65,000,000
3.8
MCPEAK MERRILL A Non-Executive Director
Transaction date
Purchase
Price
6.31
Quantity 10,000 +4.4%
Value US$63,100
3.8
MCPEAK MERRILL A Non-Executive Director
Transaction date
Purchase
Price
6.18
Quantity 10,000 +4.6%
Value US$61,800
4.0
Vogt Frederick G Interim CEO & General Counsel Officer
Transaction date
Purchase
Price
5.98
Quantity 1,000 +100.0%
Value US$5,980
2.2
Dukes Iain D. Non-Executive Director
Transaction date
Purchase
Price
6.10
Quantity 10,000 +83.3%
Value US$61,000
2.9
Rothbaum Wayne P. Non-Executive Director
Transaction date
Purchase
Price
6.43
Quantity 500,000 +6.6%
Value US$3,215,500
4.0
Vogt Frederick G Interim CEO & General Counsel Officer
Transaction date
Purchase
Price
6.44
Quantity 1,000 +inf%
Value US$6,440
3.8
MCPEAK MERRILL A Non-Executive Director
Transaction date
Purchase
Price
6.80
Quantity 10,000 +4.8%
Value US$68,000
3.8
MCPEAK MERRILL A Non-Executive Director
Transaction date
Purchase
Price
6.84
Quantity 10,000 +98.5%
Value US$68,400
2.9
Rothbaum Wayne P. Non-Executive Director
Transaction date
Purchase
Price
6.77
Quantity 500,000 +7.1%
Value US$3,384,550
3.3
WEISER MICHAEL Non-Executive Director
Transaction date
Purchase
Price
6.80
Quantity 7,813 +7.5%
Value US$53,128
3.3
WEISER MICHAEL Non-Executive Director
Transaction date
Purchase
Price
6.79
Quantity 2,187 +2.1%
Value US$14,850
3.3
Maynard Ryan D Non-Executive Director
Transaction date
Purchase
Price
6.75
Quantity 7,500 +inf%
Value US$50,588
Dukes Iain D. Non-Executive Director
Transaction date
Purchase
Price
8.65
Quantity 12,000 +inf%
Value US$103,796
MCPEAK MERRILL A Non-Executive Director
Transaction date
Purchase
Price
9.63
Quantity 10,000 +2.2%
Value US$96,273
Rothbaum Wayne P. Non-Executive Director
Transaction date
Purchase
Price
9.86
Quantity 300,000 +4.4%
Value US$2,958,000
Rothbaum Wayne P. Non-Executive Director
Transaction date
Purchase
Price
10.31
Quantity 921,053 +15.8%
Value US$9,496,056
Hillsberg Sanford Non-Executive Director
Transaction date
Sale
Price
9.11
Quantity 54,000 -35.1%
Value US$491,740
Hillsberg Sanford Non-Executive Director
Transaction date
Sale
Price
7.13
Quantity 16,500 -9.7%
Value US$117,645
Hillsberg Sanford Non-Executive Director
Transaction date
Sale
Price
6.84
Quantity 16,000 -8.6%
Value US$109,440
Hillsberg Sanford Non-Executive Director
Transaction date
Sale
Price
8.15
Quantity 32,500 -14.8%
Value US$264,875
Hillsberg Sanford Non-Executive Director
Transaction date
Sale
Price
10.00
Quantity 50,000 -18.6%
Value US$500,000
Ayer Capital Management, LP Large shareholder
Transaction date
Sale
Price
9.62
Quantity 2,780,682 -49.6%
Value US$26,752,385
BRISTOL INVESTMENT FUND LTD Large shareholder
Transaction date
Sale
Price
690,000.00
Quantity 100,000 -2.5%
Value US$69,000,000,000
MCPEAK MERRILL A/ Non-Executive Director
Transaction date
Purchase
Price
2.00
Quantity 50,000 +14.4%
Value US$100,000
Singh Manish President & CEO Executive Director Large shareholder
Transaction date
Purchase
Price
2.00
Quantity 125,000 +6.9%
Value US$250,000
MCPEAK MERRILL A/ Non-Executive Director
Transaction date
Purchase
Price
1.40
Quantity 10,000 +inf%
Value US$14,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-06 2025-06-05 B Purchase
2.3
Kirby Daniel Gordon

Chief Commercial Officer

Officer
65,854 +42.9%
152.58
US$4,230,550 		65,854 +42.9% 152.58 US$4,230,550
2025-05-27 2025-05-23 B Purchase
3.1
Puri Raj K.

Chief Regulatory Officer

Officer
66,236 +1.3%
250.11
US$3,411,752 		66,236 +1.3% 250.11 US$3,411,752
2025-05-16 2025-05-14 B Purchase
4.0
Vogt Frederick G

Interim CEO & General Counsel

Executive Director
15,007 +26.4%
10.63
US$4,039,378 		15,007 +26.4% 10.63 US$4,039,378
2024-11-14 2024-11-12 S Sale
3.3
Maynard Ryan D
Non-Executive Director
50,000 -87.0%
10.06
US$503,000 		50,000 -87.0% 10.06 US$503,000
2024-11-12 2024-11-12 PrS Proposed sale
3.3
Maynard Ryan D

Director

Non-Executive Director
50,000
10.06
US$503,104 		50,000 10.06 US$503,104
2024-02-20 2024-02-20 B Purchase
3.8
MCPEAK MERRILL A
Non-Executive Director
250,000 +356.4%
9.15
US$2,287,500 		250,000 +356.4% 9.15 US$2,287,500
2024-02-20 2024-02-20 B Purchase
2.9
Rothbaum Wayne P.
Non-Executive Director
5,000,000 +21.7%
9.15
US$45,750,000 		5,000,000 +21.7% 9.15 US$45,750,000
2024-02-20 2024-02-20 B Purchase
2.2
Dukes Iain D.
Non-Executive Director
32,000 +145.5%
9.15
US$292,800 		32,000 +145.5% 9.15 US$292,800
2023-09-19 2023-09-18 B Purchase
3.8
MCPEAK MERRILL A
Non-Executive Director
10,000 +4.2%
5.56
US$55,600 		10,000 +4.2% 5.56 US$55,600
2023-09-15 2023-09-15 B Purchase
2.9
Rothbaum Wayne P.
Non-Executive Director
5,000,000 +27.7%
5.30
US$26,500,000 		5,000,000 +27.7% 5.30 US$26,500,000
2022-12-22 2022-12-21 B Purchase
3.8
MCPEAK MERRILL A
Non-Executive Director
10,000 +16.6%
6.15
US$61,500 		10,000 +16.6% 6.15 US$61,500
2022-12-02 2022-12-02 B Purchase
2.9
Rothbaum Wayne P.
Non-Executive Director
10,000,000 +124.0%
6.50
US$65,000,000 		10,000,000 +124.0% 6.50 US$65,000,000
2022-11-30 2022-11-29 B Purchase
3.8
MCPEAK MERRILL A
Non-Executive Director
10,000 +4.4%
6.31
US$63,100 		10,000 +4.4% 6.31 US$63,100
2022-11-28 2022-11-28 B Purchase
3.8
MCPEAK MERRILL A
Non-Executive Director
10,000 +4.6%
6.18
US$61,800 		10,000 +4.6% 6.18 US$61,800
2022-11-28 2022-11-28 B Purchase
4.0
Vogt Frederick G

Interim CEO & General Counsel

Officer
1,000 +100.0%
5.98
US$5,980 		1,000 +100.0% 5.98 US$5,980
2022-11-28 2022-11-23 B Purchase
2.2
Dukes Iain D.
Non-Executive Director
10,000 +83.3%
6.10
US$61,000 		10,000 +83.3% 6.10 US$61,000
2022-06-02 2022-06-01 B Purchase
2.9
Rothbaum Wayne P.
Non-Executive Director
500,000 +6.6%
6.43
US$3,215,500 		500,000 +6.6% 6.43 US$3,215,500
2022-06-02 2022-06-01 B Purchase
4.0
Vogt Frederick G

Interim CEO & General Counsel

Officer
1,000 +inf%
6.44
US$6,440 		1,000 +inf% 6.44 US$6,440
2022-06-02 2022-05-31 B Purchase
3.8
MCPEAK MERRILL A
Non-Executive Director
10,000 +4.8%
6.80
US$68,000 		10,000 +4.8% 6.80 US$68,000
2022-06-02 2022-05-31 B Purchase
3.8
MCPEAK MERRILL A
Non-Executive Director
10,000 +98.5%
6.84
US$68,400 		10,000 +98.5% 6.84 US$68,400
2022-06-02 2022-05-31 B Purchase
2.9
Rothbaum Wayne P.
Non-Executive Director
500,000 +7.1%
6.77
US$3,384,550 		500,000 +7.1% 6.77 US$3,384,550
2022-06-02 2022-05-31 B Purchase
3.3
WEISER MICHAEL
Non-Executive Director
7,813 +7.5%
6.80
US$53,128 		7,813 +7.5% 6.80 US$53,128
2022-06-02 2022-05-31 B Purchase
3.3
WEISER MICHAEL
Non-Executive Director
2,187 +2.1%
6.79
US$14,850 		2,187 +2.1% 6.79 US$14,850
2022-06-02 2022-05-31 B Purchase
3.3
Maynard Ryan D
Non-Executive Director
7,500 +inf%
6.75
US$50,588 		7,500 +inf% 6.75 US$50,588
2018-12-20 2018-12-18 B Purchase Dukes Iain D. Non-Executive Director
12,000 +inf%
8.65
US$103,796 		12,000 +inf% 8.65 US$103,796
2018-12-14 2018-12-13 B Purchase MCPEAK MERRILL A Non-Executive Director
10,000 +2.2%
9.63
US$96,273 		10,000 +2.2% 9.63 US$96,273
2018-12-07 2018-12-06 B Purchase Rothbaum Wayne P. Non-Executive Director
300,000 +4.4%
9.86
US$2,958,000 		300,000 +4.4% 9.86 US$2,958,000
2018-12-07 2018-12-04 B Purchase Rothbaum Wayne P. Non-Executive Director
921,053 +15.8%
10.31
US$9,496,056 		921,053 +15.8% 10.31 US$9,496,056
2016-08-24 2016-08-22 S Sale Hillsberg Sanford Non-Executive Director
54,000 -35.1%
9.11
US$491,740 		54,000 -35.1% 9.11 US$491,740
2015-09-09 2015-09-08 S Sale Hillsberg Sanford Non-Executive Director
16,500 -9.7%
7.13
US$117,645 		16,500 -9.7% 7.13 US$117,645
2015-09-09 2015-09-04 S Sale Hillsberg Sanford Non-Executive Director
16,000 -8.6%
6.84
US$109,440 		16,000 -8.6% 6.84 US$109,440
2015-08-04 2015-08-03 S Sale Hillsberg Sanford Non-Executive Director
32,500 -14.8%
8.15
US$264,875 		32,500 -14.8% 8.15 US$264,875
2015-05-07 2015-05-06 S Sale Hillsberg Sanford Non-Executive Director
50,000 -18.6%
10.00
US$500,000 		50,000 -18.6% 10.00 US$500,000
2015-05-08 2015-05-01 S Sale Ayer Capital Management, LP Large shareholder
2,780,682 -49.6%
9.62
US$26,752,385 		2,780,682 -49.6% 9.62 US$26,752,385
2014-11-07 2014-11-06 S Sale BRISTOL INVESTMENT FUND LTD Large shareholder
100,000 -2.5%
690,000.00
US$69,000,000,000 		100,000 -2.5% 690,000.00 US$69,000,000,000
2013-11-12 2013-11-05 B Purchase MCPEAK MERRILL A/ Non-Executive Director
50,000 +14.4%
2.00
US$100,000 		50,000 +14.4% 2.00 US$100,000
2013-11-07 2013-11-05 B Purchase Singh Manish

President & CEO

Executive Director Large shareholder
125,000 +6.9%
2.00
US$250,000 		125,000 +6.9% 2.00 US$250,000
2011-09-26 2011-07-21 B Purchase MCPEAK MERRILL A/ Non-Executive Director
10,000 +inf%
1.40
US$14,000 		10,000 +inf% 1.40 US$14,000
Explore more

More insider trading research around Iovance Biotherapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America